Buprecare Multidose 0.3 mg/ml Solution for Injection for Dogs and Cats
Buprecare Multidose 0.3 mg/ml Solution for Injection for Dogs and Cats
Authorised
- Buprenorphine hydrochloride
Product identification
Medicine name:
Buprecare Multidose 0.3 mg/ml Solution for Injection for Dogs and Cats
Buprecare Multidose 0.3 mg/ml Solution injectable
Active substance:
- Buprenorphine hydrochloride
Target species:
-
Dog
-
Cat
Route of administration:
-
Intramuscular use
-
Intravenous use
Product details
Active substance and strength:
-
Buprenorphine hydrochloride0.32/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN02AE01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Luxembourg
Package description:
- Presented in a 10 ml amber Type I glass vial with a bromobutyl rubber stopper and flip-off aluminium cap.Pack size: 1 vial with 10 ml solution for injection.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ecuphar
Marketing authorisation date:
Manufacturing sites for batch release:
- Produlab Pharma B.V.
Responsible authority:
- Ministry Of Health And Social Security
Authorisation number:
- V/991/19/09/1055
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0453/002
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
France
-
Germany
-
Greece
-
Hungary
-
Luxembourg
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
